© 2020 MJH Life Sciences and Modern Retina. All rights reserved.
© 2020 MJH Life Sciences™ and Modern Retina. All rights reserved.
Aflibercept, an anti-VEGF agent, can enable treatment interval extensions and provide rapid and sustained vision gain in retinal vascular diseases as well as significantly reducing the severity of diabetic retinopathy.